At InMode we strive to create innovative, life changing technologies that will lead the industry in enhancing beauty and well-being. Our procedures utilise the most innovative radio frequency, light-based energy and laser technologies, enabling a new emergence of minimally invasive procedures to improve existing surgical procedures.
THE WORLD’S MOST ANTICIPATED INNOVATION
IN FACIAL AESTHETICS
THE SURGEON'S PRECISION TOOL
Bridge the gap between surgical and non-surgical facial contouring, without the scars and minimal to no downtime. AccutTite and FaceTite technologies offer control, precision, accuracy and innovation only available to medical professionals.
AccuTite is the smallest minimally invasive radiofrequency contraction device on the market. AccuTite delivers precision heating to small and delicate areas of the face and body
An advanced contouring system to treat a patient’s face and their small areas. FaceTite is minimally invasive and is the next best alternative to facelifts without the invasive surgery.
RF Microneedling technology to target deep layers of a patient’s skin and remodel collagen.
Embrace RF By InMode: Like No Other
Despite having a significantly lower population, in 2018, the Australasian College of Cosmetic Surgery revealed that, within the year, Australians spent more on cosmetic procedures than Americans, expending more than $1 billion a year on addressing their aesthetic concerns.
OFFER YOUR PATIENTS THE MOST ADVANCED FACIAL CONTOURING AND REFINEMENT PROCEDURE AVAILABLE THROUGH ‘INJECTABLE RF’:
- Precision on fat reduction or skin contraction avoiding excisional surgery
- AccuTite has the smallest and most preciseheating technology for difficult to reach are as such as brows, periorbital, nasolabial fold, lower face and neck
- AccuTite cannula is the same size as an18-guage injectable needle
- In-office procedures and available under local anaesthesia
- High ROI
- Multiple revenue streams
Contact us today to learn more about our portfolio of tips and learn how to make the most of EmbraceRF treatments.